Century Therapeutics, Inc. (IPSC)
1.42
-0.08
(-5.33%)
USD |
NASDAQ |
Oct 16, 15:17
Century Therapeutics SG&A Expense (TTM) : 20.16M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.16M |
| March 31, 2026 | 22.18M |
| December 31, 2025 | 24.00M |
| September 30, 2025 | 30.80M |
| June 30, 2025 | 32.32M |
| March 31, 2025 | 32.82M |
| December 31, 2024 | 33.16M |
| September 30, 2024 | 33.99M |
| June 30, 2024 | 34.62M |
| March 31, 2024 | 34.55M |
| December 31, 2023 | 34.71M |
| September 30, 2023 | 34.36M |
| June 30, 2023 | 33.44M |
| Date | Value |
|---|---|
| March 31, 2023 | 33.46M |
| December 31, 2022 | 31.86M |
| September 30, 2022 | 29.79M |
| June 30, 2022 | 28.01M |
| March 31, 2022 | 23.84M |
| December 31, 2021 | 19.24M |
| September 30, 2021 | 13.06M |
| June 30, 2021 | 9.095M |
| March 31, 2021 | 7.317M |
| December 31, 2020 | 6.679M |
| September 30, 2020 | 6.679M |
| June 30, 2020 | 4.36M |
| March 31, 2020 | 2.05M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tenax Therapeutics, Inc. | 23.36M |
| Exicure, Inc. | 5.28M |
| Absci Corp. | 35.28M |
| Celularity, Inc. | 37.00M |
| Cardio Diagnostics Holdings, Inc. | 3.501M |